Evidence Hub

Non‐differential gut microbes contribute to hypertension and its severity through co‐abundances: A multi‐regional prospective cohort study

Lu Liu, Qian-Yi Zhou, Tian Xu, Qiufeng Deng, Yuhao Sun, Jingxiang Fu, Muxuan Chen, Xiaojiao Chen et al.

iMeta, 2025

22 citations

Abstract

Abstract Microbial dysbiosis, characterized by an imbalanced microbial community structure and function, has been linked to hypertension. While prior research has primarily focused on differential abundances, our study highlights the role of non‐differential microbes in hypertension. We propose that non‐differential microbes contribute to hypertension through their ecological interactions, as defined by co‐abundances (pairs of microbes exhibiting correlated abundance patterns). Using gut microbiome data from the Guangdong Gut Microbiome Project, which includes 2355 hypertensive and 4644 non‐hypertensive participants across 14 regions, we identified replicable hypertension‐related microbial interactions. Notably, most co‐abundances involved non‐differential microbes, which were found to correlate with both hypertension severity and hypertension‐related microbial metabolic pathways. These findings emphasize the importance of microbial interactions in hypertension pathogenesis and propose a novel perspective for microbiome‐based therapeutic strategies.

How strong is the evidence?

Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free